HLF Stock Recent News
HLF LATEST HEADLINES
LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd., a premier health and wellness company, will release its third quarter 2023 financial results after the close of trading on the NYSE on Wednesday, November 1, 2023. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), the Company's senior management team will host a live audio webcast and conference call to discuss its recent financial results and provide an update on current business trends. The live audio webcast will be available at https://edge.media.
Herbalife's Director of Quality Control Lab, Quanyin Gao, appointed to AOAC Technical Programming Council LOS ANGELES , Aug. 24, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company, announced today that 16 members of its Quality Control and Research and Development (R&D) scientific teams will participate at the 2023 AOAC (Association of Official Agricultural Chemists) INTERNATIONAL Meeting and Exposition in New Orleans, Louisiana, August 25-30. Additionally, Herbalife's director of Quality Control Labs, Quanyin Gao, Ph.D.
David Rosenberg took a jab at billionaire investor Bill Ackman for his bet against US Treasurys. The top economist said falling US rents could see inflation "melt," suggesting the Fed could end its hikes.
Herbalife Ltd (HLF) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.96 per share a year ago.
Herbalife's stock is currently undervalued, trading at a 10-year low on operating results, making it a potentially attractive investment opportunity. An overly-aggressive short position betting against Herbalife could trigger a "short squeeze" scenario if the company's sales and earnings improve as predicted by Wall Street analysts. Herbalife's management has been using free cash flow to buy back stock, steadily increasing value for remaining shareholders while eliminating share supply for short sellers.
The Zacks Retail Pharmacy and Drugstore industry players like CVS, HLF and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.
Herbalife is a controversial business with a fair share of risks associated with its operations. The recent post-covid sell-off has been excessive, leading to a deep-value opportunity. A 65% undervaluation has created a real opportunity for a mid-term intrinsic value play.
Herbalife Ltd. (NYSE:HLF ) Q1 2023 Earnings Conference Call May 2, 2023 5:30 PM ET Company Participants Erin Banyas - Vice President & Head, Investor Relations Michael Johnson - Chairman & Chief Executive Officer Alex Amezquita - Chief Financial Officer Mark Schissel - Chief Operating Officer Conference Call Participants Chasen Bender - Citi Jeff Van Sinderen - B.
Herbalife Ltd. HLFshares declined in after-hours trading Tuesday, after the multilevel-marketing firm missed expectations with its first-quarter earnings.
LOS ANGELES--(BUSINESS WIRE)--Herbalife Nutrition Ltd., a global health and wellness company and community, will release its first quarter 2023 financial results after the close of trading on the NYSE on Tuesday, May 2, 2023. The same day, at 5:30 p.m. ET (2:30 p.m. PT), the Company's senior management team will host an investor conference call to discuss its recent financial results and provide an update on current business trends.